Alnylam Pharmaceuticals is to invest $250m to expand its facility in Massachusetts, US, to meet the growing demand for RNAi ...

Aptar Group said its intranasal medical delivery technology will be used to administer Cardamyst, a treatment for paroxysmal supraventricular tachycardia in adults.

Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies, explores how advanced technologies are being used to reduce risk ...

The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, ...

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw ...

Andrew Anderson shares insights on the factors that may shape the next major advance in pharmaceutical informatics strategy.

The CNPV program significantly reduces drug review times, necessitating operational shifts for sponsors to meet compressed ...